Advertisement
Screener

Tandem Diabetes Care, Inc. (TNDM) Paid-in-Kind Interest

2.6 / 5 stars · 51/98 Roast Me

Tandem Diabetes Care, Inc. Paid-in-Kind Interest

Tandem Diabetes Care, Inc. (TNDM) reported Paid-in-Kind Interest of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:PaidInKindInterest · last filed 2020-02-24

  • Tandem Diabetes Care, Inc. paid-in-kind interest for the quarter ending 2017-12-31 was $421.00K, a 67.06% increase year-over-year.
  • Tandem Diabetes Care, Inc. paid-in-kind interest for the quarter ending 2017-09-30 was $419.00K, a 78.30% increase year-over-year.
  • Tandem Diabetes Care, Inc. paid-in-kind interest for the quarter ending 2017-06-30 was $412.00K, a 80.70% increase year-over-year.
  • Tandem Diabetes Care, Inc. paid-in-kind interest for the quarter ending 2017-03-31 was $405.00K, a 91.04% increase year-over-year.
  • Tandem Diabetes Care, Inc. paid-in-kind interest for fiscal 2019 was $0.00.
  • Tandem Diabetes Care, Inc. paid-in-kind interest for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
  • Tandem Diabetes Care, Inc. paid-in-kind interest for fiscal 2017 was $1.66M, a 78.75% increase from fiscal 2016.
  • Tandem Diabetes Care, Inc. paid-in-kind interest for fiscal 2016 was $927.00K, a 505.88% increase from fiscal 2015.
Period endPaid-in-Kind Interest 3 monthPaid-in-Kind Interest 3 month as first filedPaid-in-Kind Interest 6 monthPaid-in-Kind Interest 9 monthPaid-in-Kind Interest 12 monthPaid-in-Kind Interest 18 monthPaid-in-Kind Interest 21 monthPaid-in-Kind Interest 24 monthPaid-in-Kind Interest 27 month
2019-12-31$0.00
10-K · filed 2020-02-24
2018-12-31$0.00
10-K · filed 2020-02-24
2017-12-31$421.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
$840.00K
derived: sum of 2 quarters · filed 2020-02-24
$1.25M
derived: sum of 3 quarters · filed 2020-02-24
$1.66M
10-K · filed 2020-02-24
$2.70M
10-K · filed 2019-02-26
2017-09-30$419.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$831.00K
derived: sum of 2 quarters · filed 2018-11-01
$1.24M
10-Q · filed 2018-11-01
$1.49M
derived: sum of 4 quarters · filed 2019-02-26
$2.30M
10-Q · filed 2017-10-26
2017-06-30$412.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30
$817.00K
10-Q · filed 2018-07-30
$1.07M
derived: sum of 3 quarters · filed 2019-02-26
$1.30M
derived: sum of 4 quarters · filed 2019-02-26
$1.90M
10-Q · filed 2017-07-27
2017-03-31$405.00K
10-Q · filed 2018-04-26
$657.00K
derived: sum of 2 quarters · filed 2019-02-26
$892.00K
derived: sum of 3 quarters · filed 2019-02-26
$1.12M
derived: sum of 4 quarters · filed 2019-02-26
$1.50M
10-Q · filed 2017-04-27
2016-12-31$252.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$487.00K
derived: sum of 2 quarters · filed 2019-02-26
$715.00K
derived: sum of 3 quarters · filed 2019-02-26
$927.00K
10-K · filed 2019-02-26
2016-09-30$235.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26
$463.00K
derived: sum of 2 quarters · filed 2017-10-26
$675.00K
10-Q · filed 2017-10-26
$875.00K
derived: sum of 4 quarters · filed 2017-10-26
2016-06-30$228.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27
$440.00K
10-Q · filed 2017-07-27
$640.00K
derived: sum of 3 quarters · filed 2017-07-27
2016-03-31$212.00K
10-Q · filed 2017-04-27
$412.00K
derived: sum of 2 quarters · filed 2017-04-27
2015-12-31$200.00K
10-K · filed 2017-03-08
$153.00K
10-Q · filed 2016-11-01
$153.00K
10-K · filed 2018-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRADIMED CORP (IRMD)United States$1.089B52.92
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
ARTIVION, INC. (AORT)United States$1.123B-345.09
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
SpyGlass Pharma, Inc. (SGP)United States$0.925B
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B